Oxford Immunotec Global PLC 3 SEC Filings

Filed On	Filing
20 Nov 2019	Form 3: Kidd Janet Louise, General Counsel No securities owned
10 Apr 2019	Form 3: McLaughlin Matthew T E, Chief Financial Officer No securities owned
02 Mar 2018	Form 3: Klausner Mark R., Director No securities owned
30 Aug 2017	Form 3: Linn Stefan C, Chief Operating Officer No securities owned
26 Jul 2017	Form 3: Wenstrup Richard, Chief Medical Officer No securities owned
02 Feb 2016	Form 3: Balthrop Patrick J, Director No securities owned
06 Nov 2015	Form 3: Walton Andrew Scott, Director No securities owned
06 Nov 2015	Form 3: Andrews Ronald Asbury, Director No securities owned
06 Jan 2015	Form 3: Keiley Elizabeth M, VP & General Counsel
22 Nov 2013	Form 3: Steinmetz Michael, Director Holds 2,579,062 shares of Ordinary Shares
21 Nov 2013	Form 3: Altieri Richard M., Chief Financial Officer
21 Nov 2013	Form 3: Lathi Vijay K, Director Holds 1,377,497 shares of Ordinary Shares
21 Nov 2013	Form 3: New Leaf Ventures II, L.p., Director and 7 others Holds 1,377,497 shares of Ordinary Shares
21 Nov 2013	Form 3: Schroeder Jeff R., Chief Commercial Officer
21 Nov 2013	Form 3: Pitchford Nigel A., Director Holds 833,448 shares of Ordinary Shares
21 Nov 2013	Form 3: Edwardson Peter, Chief Operations Officer
21 Nov 2013	Form 3: Wrighton-Smith Peter, Director Holds 355,741 shares of Ordinary Shares
21 Nov 2013	Form 3: Sandberg Richard A, Director Holds 53,674 shares of Ordinary Shares
21 Nov 2013	Form 3: Randall Patricia, VP and General Counsel
21 Nov 2013	Form 3: Rosenman Herm, Director No securities owned

Comments